Temedica GmbH. (1/14/20). "Press Release: Temedica Raises $19 Million Series B Funding". Munich. - [LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe
Summary
Document DetailsIn order to further strengthen its position as an innovation driver in the fast-growing digital health market, Temedica has closed a Series B financing round of $19 million. The round was led by MIG Funds, Santo Venture Capital and Salvia, along with existing investors such as Bernd Wendeln and G+J Digital Ventures.Digital health company Temedica has successfully completed a $19 million Series B financing round led by the MIG funds, Santo Venture Capital and Salvia.Temedica develops digital therapy companions as smartphone apps that aim to support patients\x92 healing process and to ensure sustainable medical care. With MIG, Santo and Salvia we gain valuable expertise in the healthcare market and strong partners for the upcoming expansion of the organization.Michael Motschmann, General Partner of MIG AG, says:With Temedicas intelligent digital approach we complement our traditionally strong foothold in the health sector. Through the MIG funds, young companies are provided with the financial means to establish and finance growth in the hightech and life science sectors.For further information: www.mig.ag | www.mig-fonds.deABOUT SANTOSanto Venture Capital GmbH is the venture arm of ATHOS KG, the family office of the Str\xfcngmann families.CONTACTGloria Seibert, Gr\xfcnderin & CEOgloria.seibert@temedica.com [1] Temedica GmbH. "Press Release: Temedica Announces Cooperation with Bristol Myers Squibb for the Development of a Digital Companion for Psoriasis Patients".